Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Submitted by
admin
on October 6, 2015 - 9:51am
Source:
Bidness, ETC
News Tags:
PAH
pulmonary arterial hypertension
FDA
Gilead Sciences
Letairis
Headline:
Gilead Sciences Letairis Wins FDA Nod For PAH: Stock To Recover Soon
Do Not Allow Advertisers to Use My Personal information
